Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -11.97 Million USD | -116.24% |
| 2021 | -5.53 Million USD | -160.19% |
| 2020 | -2.12 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -2.5 Million USD | 16.9% |
| 2023 Q3 | -2.15 Million USD | -45.73% |
| 2023 Q2 | -1.48 Million USD | 40.8% |
| 2022 Q3 | -2.53 Million USD | 36.18% |
| 2022 Q2 | -3.97 Million USD | -61.98% |
| 2022 Q1 | -2.45 Million USD | -21.17% |
| 2022 FY | -11.97 Million USD | -116.24% |
| 2022 Q4 | -3 Million USD | -18.68% |
| 2021 Q4 | -2.02 Million USD | -121.53% |
| 2021 Q3 | -913.7 Thousand USD | 52.01% |
| 2021 Q2 | -1.9 Million USD | -174.4% |
| 2021 Q1 | -693.8 Thousand USD | 0.0% |
| 2021 FY | -5.53 Million USD | -160.19% |
| 2020 FY | -2.12 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| America Great Health | -492.64 Thousand USD | -2329.749% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -25.762% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | 60.091% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 82.172% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | 24.446% |
| Better Therapeutics, Inc. | -38.26 Million USD | 68.716% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 71.55% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | 64.632% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | 65.223% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 88.964% |
| Evolutionary Genomics, Inc. | -2.01 Million USD | -494.251% |
| Finch Therapeutics Group, Inc. | -34 Million USD | 64.796% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 74.505% |
| Innovation1 Biotech Inc. | -1.36 Million USD | -775.394% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | 39.968% |
| Molecular Templates, Inc. | -10.46 Million USD | -14.37% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | 14.81% |
| NexImmune, Inc. | -29.19 Million USD | 58.996% |
| Orgenesis Inc. | -53.63 Million USD | 77.683% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 76.664% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -15242.829% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 25.861% |
| Scopus BioPharma Inc. | -11.71 Million USD | -2.178% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 97.626% |
| Statera Biopharma, Inc. | -98.34 Million USD | 87.828% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -73.529% |
| Trevena, Inc. | -35.28 Million USD | 66.079% |
| Vaxxinity, Inc. | -58.28 Million USD | 79.463% |
| Vaccinex, Inc. | -22.88 Million USD | 47.695% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -1043.292% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 76.387% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -64.808% |